HEALTH OF WOMAN. 2018.7(133):134–139

Номер 743 • Липень 2018 р.
скорочений варіант

СПИСОК ЛІТЕРАТУРИ

1. American College of Obstetricians and Gynecologists. Hypertension in pregnancy. Washington, DC: American College of Obstetricians and Gynecologists; 2013. Available at: http://www.acog.org/Resources-And-Publications/Task- Force-and-Work-Group-Reports/Hypertension-in-Preg- nancy. Retrieved January 24, 2018.

2. LeFevre ML. Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preven- tive Services Task Force recommendation statement. U.S. Preventive Services Task Force. Ann Intern Med 2014;161: 819–26.

3. World Health Organization. WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia. Geneva (Switzerland): WHO; 2011. Available at: http:// apps.who.int/iris/bitstream/10665/44703/1/9789241548335_ eng.pdf. Retrieved January 24, 2018.

4. National Institute for Health and Care Excellence. Hyper- tension in pregnancy: quality standard. Manchester (United Kingdom): NICE; 2013. Available at: https:// www.nice.org.uk/guidance/qs35/resources/hypertension- in-pregnancy-2098607923141. Retrieved January 26, 2018.

5. Clarke RJ, Mayo G, Price P, FitzGerald GA. Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin. N Engl J Med 1991;325:1137–41. 


6. Patrono C. Aspirin as an antiplatelet drug. N Engl J Med 1994;330:1287–94. 


7. Benigni A, Gregorini G, Frusca T, Chiabrando C, Ballerini S, Valcamonico A, et al. Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension. N Engl J Med 1989;321:357–62. 


8. Schiff E, Peleg E, Goldenberg M, Rosenthal T, Ruppin E, Tamarkin M, et al. The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies. N Engl J Med 1989;321:351–6. 


9. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005;365:785–99. 


10. Coomarasamy A, Papaioannou S, Gee H, Khan KS. Aspirin for the prevention of preeclampsia in women with abnor- mal uterine artery Doppler: a meta-analysis. Obstet Gyne- col 2001;98:861–6. 


11. Scazzocchio E, Oros D, Diaz D, Ramirez JC, Ricart M, Meler E, et al. Impact of aspirin on trophoblastic invasion in women with abnormal uterine artery Doppler at 11–14 weeks: a randomized controlled study. Ultrasound Obstet Gynecol 2017;49:435–41. 


12. Duley L, Henderson-Smart DJ, Meher S, King JF. Antipla- telet agents for preventing pre-eclampsia and its complica- tions. Cochrane Database of Systematic Reviews 2007, Issue 2. Art. No.: CD004659. 


13. Askie LM, Duley L, Henderson-Smart DJ, Stewart LA. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. PARIS Collabo- rative Group. Lancet 2007;369:1791–8. 


14. Henderson JT, Whitlock EP, O’Connor E, Senger CA, Thompson JH, Rowland MG. Low-dose aspirin for preven- tion of morbidity and mortality from preeclampsia: a sys- tematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med 2014;160:695–703. 


15. De Berardis G, Lucisano G, D’Ettorre A, Pellegrini F, Lep- ore V, Tognoni G, et al. Association of aspirin use with major bleeding in patients with and without diabetes. JA- MA 2012;307:2286–94. 


16. CLASP: a randomised trial of low-dose aspirin for the pre- vention and treatment of pre-eclampsia among 9364 preg- nant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. Lancet 1994; 343:619–29.

17. Ahrens KA, Silver RM, Mumford SL, Sjaarda LA, Perkins NJ, Wactawski-Wende J, et al. Complications and safety of preconception low-dose aspirin among women with prior pregnancy losses. Obstet Gynecol 2016;127:689–98. 


18. Slone D, Siskind V, Heinonen OP, Monson RR, Kaufman DW, Shapiro S. Aspirin and congenital malformations. Lancet 1976;1:1373–5. 


19. Werler MM, Mitchell AA, Shapiro S. First trimester mater- nal medication use in relation to gastroschisis. Teratology 1992;45:361–7.

20. Werler MM, Sheehan JE, Mitchell AA. Maternal medica- tion use and risks of gastroschisis and small intestinal atre- sia. Am J Epidemiol 2002;155:26–31.

21. Martinez-Frias ML, Rodriguez-Pinilla E, Prieto L. Prenatal exposure to salicylates and gastroschisis: a case-control study. Teratology 1997;56:241–3.

22. Kozer E, Nikfar S, Costei A, Boskovic R, Nulman I, Koren G. Aspirin consumption during the first trimester of preg- nancy and congenital anomalies: a meta-analysis. Am J Obstet Gynecol 2002;187:1623–30.

23. Sibai BM, Mirro R, Chesney CM, Leffler C. Low-dose aspi- rin in pregnancy. Obstet Gynecol 1989;74:551–7.

24. Wyatt-Ashmead J. Antenatal closure of the ductus arterio- sus and hydrops fetalis. Pediatr Dev Pathol 2011;14:469–74.

25. Levin DL, Mills LJ, Parkey M, Garriott J, Campbell W. Constriction of the fetal ductus arteriosus after administra- tion of indomethacin to the pregnant Ewe. J Pediatr 1979; 94:647–50.

26. Coomarasamy A, Honest H, Papaioannou S, Gee H, Khan KS. Aspirin for prevention of preeclampsia in women with historical risk factors: a systematic review. Obstet Gynecol 2003;101:1319–32.

27. Elsevier. Clinical pharmacology. Available at: http://www. clinicalpharmacology.com/. Retrieved March 20, 2018.

28. Roberge S, Nicolaides KH, Demers S, Villa P, Bujold E. Prevention of perinatal death and adverse perinatal out- come using low-dose aspirin: a meta-analysis. Ultrasound Obstet Gynecol 2013;41:491–9.

29. Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, et al. Prevention of preeclampsia and intrauter- ine growth restriction with aspirin started in early preg- nancy: a meta-analysis. Obstet Gynecol 2010;116:402–14.

30. Roberge S, Bujold E, Nicolaides KH. Aspirin for the pre- vention of preterm and term preeclampsia: systematic review and metaanalysis. Am J Obstet Gynecol 2017;218: 287–93.e1.

31. Roberge S, Nicolaides K, Demers S, Hyett J, Chaillet N, Bujold E. The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis. Am J Obstet Gynecol 2017;216: 110–20.e6.

32. Meher S, Duley L, Hunter K, Askie L. Antiplatelet therapy before or after 16 weeks’ gestation for preventing pre- eclampsia: an individual participant data meta-analysis. Am J Obstet Gynecol 2017;216:121–8.e2.

33. Caritis S, Sibai B, Hauth J, Lindheimer MD, Klebanoff M, Thom E, et al. Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal–Fetal Medicine Units. N Engl J Med 1998;338:701–5.

34. Sibai BM, Caritis SN, Thom E, Klebanoff M, McNellis D, Rocco L, et al. Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. The National Institute of Child Health and Human Develop-ment Network of Maternal–Fetal Medicine Units. N Engl J Med 1993;329:1213–8.

35. Schisterman EF, Silver RM, Lesher LL, Faraggi D, Wactaw- ski-Wende J, Townsend JM, et al. Preconception low-dose aspirin and pregnancy outcomes: results from the EAGeR randomised trial. Lancet 2014;384:29–36. 


36. Narouze S, Benzon HT, Provenzano DA, Buvanendran A, De Andres J, Deer TR, et al. Interventional spine and pain procedures in patients on antiplatelet and anticoagulant medications: guidelines from the American Society of Regional Anesthesia and Pain Medicine, the European Society of Regional Anaesthesia and Pain Therapy, the American Academy of Pain Medicine, the International Neuromodulation Society, the North American Neuromo- dulation Society, and the World Institute of Pain. Reg Anesth Pain Med 2015;40:182–212. 


37. Wallenburg HC, Dekker GA, Makovitz JW, Rotmans P. Low-dose aspirin prevents pregnancy-induced hyperten- sion and pre-eclampsia in angiotensin-sensitive primigra- vidae. Lancet 1986;1:1–3. 


38. Low-dose aspirin in prevention and treatment of intrauter- ine growth retardation and pregnancy-induced hyperten- sion. Italian study of aspirin in pregnancy. Lancet 1993;341: 396–400. 


39. Rolnik DL, Wright D, Poon LC, O’Gorman N, Syngelaki A, de Paco Matallana C, et al. Aspirin versus placebo in preg- nancies at high risk for preterm preeclampsia. N Engl J Med 2017;377:613–22. 


40. Rai R, Backos M, Baxter N, Chilcott I, Regan L. Recurrent miscarriage—an aspirin a day? Hum Reprod 2000;15: 2220–3. 


41. Frias AE Jr, Luikenaar RA, Sullivan AE, Lee RM, Porter TF, Branch DW, et al. Poor obstetric outcome in subse- quent pregnancies in women with prior fetal death. Obstet Gynecol 2004;104:521–6. 


42. Salafia CM, Minior VK, Pezzullo JC, Popek EJ, Rosenkrantz TS, Vintzileos AM. Intrauterine growth restriction in infants of less than thirty-two weeks’ gesta- tion: associated placental pathologic features. Am J Obstet Gynecol 1995;173:1049–57. 


43. Roberge S, Giguere Y, Villa P, Nicolaides K, Vainio M, Forest JC, et al. Early administration of low-dose aspirin for the prevention of severe and mild preeclampsia: a sys- tematic review and meta-analysis [published erratum ap- pears in Am J Perinatol 2014;31:e3]. Am J Perinatol 2012; 29:551–6. 


44. Roberge S, Villa P, Nicolaides K, Giguere Y, Vainio M, Bakthi A, et al. Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis. Fetal Diagn Ther 2012; 31:141–6.

45. Wallenburg HC, Rotmans N. Prevention of recurrent idi- opathic fetal growth retardation by low-dose aspirin and dipyridamole. Am J Obstet Gynecol 1987;157:1230–5.

46. Leitich H, Egarter C, Husslein P, Kaider A, Schemper M. A meta-analysis of low dose aspirin for the prevention of intrauterine growth retardation. Br J Obstet Gynaecol 1997;104:450–9.

47. Abramovici A, Cantu J, Jenkins SM. Tocolytic therapy for acute preterm labor. Obstet Gynecol Clin North Am 2012; 39:77–87.

48. van Vliet EO, Askie LA, Mol BW, Oudijk MA. Antiplatelet agents and the prevention of spontaneous preterm birth: a systematic review and meta-analysis. Obstet Gynecol 2017;129:327–36.

49. Silver RM, Ahrens K, Wong LF, Perkins NJ, Galai N, Lesher LL, et al. Low-dose aspirin and preterm birth: a ran- domized controlled trial. Obstet Gynecol 2015;125:876–84.

50. Empson M, Lassere M, Craig JC, Scott JR. Recurrent preg- nancy loss with antiphospholipid antibody: a systematic review of therapeutic trials. Obstet Gynecol 2002;99: 135–44.

51. de Jong PG, Kaandorp S, Di Nisio M, Goddijn M, Mid- deldorp S. Aspirin and/or heparin for women with unex- plained recurrent miscarriage with or without inherited thrombophilia. Cochrane Database of Systematic Reviews 2014, Issue 7. Art. No.: CD004734.